FDA Drug Application (202124) for PARICALCITOL by RISING PHARMS INC

Back to FDA Applications sponsored by RISING PHARMS INC

Application Number202124
Product Number001
FormCAPSULE;ORAL
Dosage1MCG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePARICALCITOL
Active IngredientPARICALCITOL

Active IngredientCount
List of drugs with Active Ingredient PARICALCITOL2


Back to FDA Applications sponsored by RISING PHARMS INC